APA (7th ed.) Citation

Deslais, M., Koenig, A., Buron, F., Ouellet, G., Rabeyrin, M., Picard, C., . . . Sicard, A. (2026). Comparable outcomes with anti-thymocyte globulins versus basiliximab in kidney transplantation from controlled circulatory death donors. Transplant International, 1. https://doi.org/10.3389/ti.2026.15318

Chicago Style (17th ed.) Citation

Deslais, Martin, et al. "Comparable Outcomes with Anti-thymocyte Globulins Versus Basiliximab in Kidney Transplantation from Controlled Circulatory Death Donors." Transplant International 2026: 1. https://doi.org/10.3389/ti.2026.15318.

MLA (9th ed.) Citation

Deslais, Martin, et al. "Comparable Outcomes with Anti-thymocyte Globulins Versus Basiliximab in Kidney Transplantation from Controlled Circulatory Death Donors." Transplant International, 2026, p. 1, https://doi.org/10.3389/ti.2026.15318.